J Renal Inj Prev. 2017;6(2): 88-92. doi: 10.15171/jrip.2017.17
PMID: 28497081        PMCID: PMC5423290

Original Article

Relationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients


Cited by CrossRef: 3


1- Deng X, Huang W, Peng J, Zhu T, Sun X, Zhou X, Yang H, Xiong J, He H, Xu Y, He Y. Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling. Inflammation. 2018;41(1):260 [Crossref]
2- Gao Q, Lu C, Wang X, Zhang J, Song Y, Xue Y. Molecular dynamics simulation and steered molecular dynamics simulation on irisin dimers. J Mol Model. 2018;24(4) [Crossref]
3- Aghasi M, Ghazi-Zahedi S, Koohdani F, Siassi F, Nasli-Esfahani E, Keshavarz A, Qorbani M, Khoshamal H, Salari-Moghaddam A, Sotoudeh G. The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial. BMC Complement Altern Med. 2018;18(1) [Crossref]
4- El Haddad H, Sedrak H, Naguib M, Yousief E, Ibrahim D, Abdel Samie R, Hamdy A. Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications. Int J Diabetes Dev Ctries. 2019;39(4):641 [Crossref]